The St. Joe Company Hosts 2025 Annual Meeting of Shareholders
PANAMA CITY BEACH, Fla.–(BUSINESS WIRE)–The St. Joe Company (NYSE: JOE) (“St. Joe”) (the “Company”) concluded its 2025 Annual Meeting of Shareholders... Read more.
Mayor Lurie, Intersect Power Announce New Headquarters in Historic Downtown San Francisco Building
Continues to Cement City as Global Hub of Growing AI and Clean Energy Industries; Marks Another Key Step for Downtown Recovery Under Mayor Lurie’s Leadership SAN... Read more.
Seacoast Receives Regulatory Approvals for the Acquisition of Heartland Bancshares, Inc.
STUART, Fla.–(BUSINESS WIRE)–Seacoast Banking Corporation of Florida (“Seacoast” or the “Company”) (NASDAQ: SBCF), the holding company for Seacoast... Read more.
Luminar Announces Leadership Transition
Paul Ricci Appointed CEO ORLANDO, Fla.–(BUSINESS WIRE)–Luminar Technologies, Inc. (Nasdaq: LAZR), a leading global automotive technology company, today... Read more.
FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)
WELIREG becomes the only approved and available treatment in the U.S. for eligible patients with advanced PPGL RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck... Read more.
GeoPark Provides Update on Transaction in Vaca Muerta, Argentina
BOGOTA, Colombia–(BUSINESS WIRE)–GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent energy company with over 20... Read more.
The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1
–Data Demonstrated Statistically Significant Improvements in Primary and Secondary Endpoints with Most Subjects Achieving Near Normal Ranges of Wakefulness and... Read more.
Oceaneering to Participate at Citi’s 2025 Spotlight on SMID Energy Day
HOUSTON–(BUSINESS WIRE)–Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) announced today that Senior Vice President and Chief Financial... Read more.
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
AbCellera anticipates starting the Phase 1 clinical trial for ABCL635 in Q3 2025 VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq:... Read more.
Binarly Patents New Method for Reachability Analysis for Binary Executables
SANTA MONICA, Calif.–(BUSINESS WIRE)–Binarly, a leading firmware and software supply chain security company, has been awarded U.S. Patent No. 12,287,885... Read more.